

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | bile acid and bile salt transport (GO:0015721) | 8.53432015 |
| 2 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 8.32980458 |
| 3 | vitamin transmembrane transport (GO:0035461) | 7.84023523 |
| 4 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.53915839 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 5.44623127 |
| 6 | regulation of guanylate cyclase activity (GO:0031282) | 5.06278074 |
| 7 | cellular ketone body metabolic process (GO:0046950) | 4.96784772 |
| 8 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.93949669 |
| 9 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.90242139 |
| 10 | artery development (GO:0060840) | 4.49532973 |
| 11 | regulation of protein glycosylation (GO:0060049) | 4.47651800 |
| 12 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.44771082 |
| 13 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.40525080 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.40173736 |
| 15 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.36316997 |
| 16 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 4.32254402 |
| 17 | macrophage chemotaxis (GO:0048246) | 4.32102645 |
| 18 | ketone body metabolic process (GO:1902224) | 4.30343206 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.26522521 |
| 20 | regulation of complement activation (GO:0030449) | 4.25279973 |
| 21 | positive regulation of respiratory burst (GO:0060267) | 4.22235000 |
| 22 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.19628797 |
| 23 | ethanol oxidation (GO:0006069) | 4.16943481 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07297227 |
| 25 | complement activation, classical pathway (GO:0006958) | 4.07221408 |
| 26 | desmosome organization (GO:0002934) | 4.05612507 |
| 27 | plasma lipoprotein particle assembly (GO:0034377) | 4.02990355 |
| 28 | flavonoid metabolic process (GO:0009812) | 4.02534103 |
| 29 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.02476769 |
| 30 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.02476769 |
| 31 | kynurenine metabolic process (GO:0070189) | 3.99485189 |
| 32 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.95763494 |
| 33 | negative regulation of protein activation cascade (GO:2000258) | 3.91900229 |
| 34 | sulfate transmembrane transport (GO:1902358) | 3.90200654 |
| 35 | indole-containing compound catabolic process (GO:0042436) | 3.89059515 |
| 36 | indolalkylamine catabolic process (GO:0046218) | 3.89059515 |
| 37 | tryptophan catabolic process (GO:0006569) | 3.89059515 |
| 38 | sulfur compound transport (GO:0072348) | 3.87851091 |
| 39 | epithelial structure maintenance (GO:0010669) | 3.85227711 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.82002764 |
| 41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.78767714 |
| 42 | intestinal absorption (GO:0050892) | 3.74377473 |
| 43 | negative regulation of complement activation (GO:0045916) | 3.70538084 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.70359944 |
| 45 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.68976250 |
| 46 | intestinal epithelial cell development (GO:0060576) | 3.68421926 |
| 47 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67600166 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 3.62918215 |
| 49 | negative regulation of sterol transport (GO:0032372) | 3.62918215 |
| 50 | diacylglycerol metabolic process (GO:0046339) | 3.58401680 |
| 51 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.56033884 |
| 52 | cellular glucuronidation (GO:0052695) | 3.54989095 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.54112295 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.54036784 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.53869455 |
| 56 | tryptophan metabolic process (GO:0006568) | 3.49374045 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.48279252 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.48279252 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48279252 |
| 60 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.47740546 |
| 61 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.47594521 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 3.44395105 |
| 63 | complement activation (GO:0006956) | 3.42548058 |
| 64 | phospholipid efflux (GO:0033700) | 3.41224712 |
| 65 | protein activation cascade (GO:0072376) | 3.41112266 |
| 66 | neurotransmitter biosynthetic process (GO:0042136) | 3.38906475 |
| 67 | regulation of cGMP biosynthetic process (GO:0030826) | 3.36183069 |
| 68 | drug transmembrane transport (GO:0006855) | 3.34621140 |
| 69 | plasma lipoprotein particle organization (GO:0071827) | 3.32763078 |
| 70 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.32107853 |
| 71 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.32107853 |
| 72 | endocrine process (GO:0050886) | 3.32107853 |
| 73 | epoxygenase P450 pathway (GO:0019373) | 3.31084832 |
| 74 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.30110978 |
| 75 | regulation of histone phosphorylation (GO:0033127) | 3.26832140 |
| 76 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25004086 |
| 77 | protein carboxylation (GO:0018214) | 3.25004086 |
| 78 | regulation of interleukin-1 secretion (GO:0050704) | 3.24830870 |
| 79 | regulation of cholesterol metabolic process (GO:0090181) | 3.24612508 |
| 80 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.23210295 |
| 81 | phosphate ion transmembrane transport (GO:0035435) | 3.20841159 |
| 82 | complement activation, alternative pathway (GO:0006957) | 3.19191431 |
| 83 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.19170280 |
| 84 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.19170280 |
| 85 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.19170280 |
| 86 | cholesterol efflux (GO:0033344) | 3.19105528 |
| 87 | acute-phase response (GO:0006953) | 3.18550305 |
| 88 | bicarbonate transport (GO:0015701) | 3.18401761 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.18328194 |
| 90 | digestive system process (GO:0022600) | 3.15775712 |
| 91 | drug catabolic process (GO:0042737) | 3.15383458 |
| 92 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.15063003 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 3.14224606 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.12895795 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.12895795 |
| 96 | arginine metabolic process (GO:0006525) | 3.10974541 |
| 97 | protein-lipid complex subunit organization (GO:0071825) | 3.10226058 |
| 98 | sulfate transport (GO:0008272) | 3.10075048 |
| 99 | azole transport (GO:0045117) | 3.09475347 |
| 100 | negative regulation of humoral immune response (GO:0002921) | 3.09433705 |
| 101 | drug transport (GO:0015893) | 3.09402293 |
| 102 | regulation of respiratory burst (GO:0060263) | 3.07080716 |
| 103 | vitamin transport (GO:0051180) | 3.06789094 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05902190 |
| 105 | morphogenesis of an epithelial fold (GO:0060571) | 3.05819048 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.05236213 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 3.04193858 |
| 108 | intestinal cholesterol absorption (GO:0030299) | 3.03668056 |
| 109 | regulation of cellular extravasation (GO:0002691) | 3.00279749 |
| 110 | bile acid metabolic process (GO:0008206) | 2.97615986 |
| 111 | regulation of sterol transport (GO:0032371) | 2.97179054 |
| 112 | regulation of cholesterol transport (GO:0032374) | 2.97179054 |
| 113 | regulation of triglyceride catabolic process (GO:0010896) | 2.94665839 |
| 114 | DNA damage induced protein phosphorylation (GO:0006975) | 2.94594955 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92674192 |
| 116 | glomerular filtration (GO:0003094) | 2.91494582 |
| 117 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.90957128 |
| 118 | renal system process involved in regulation of blood volume (GO:0001977) | 2.90257852 |
| 119 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.87292576 |
| 120 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87056682 |
| 121 | glycosylceramide metabolic process (GO:0006677) | 2.86966741 |
| 122 | regulation of apoptotic cell clearance (GO:2000425) | 2.86914112 |
| 123 | positive regulation of protein targeting to membrane (GO:0090314) | 2.86023257 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.85960843 |
| 125 | exogenous drug catabolic process (GO:0042738) | 2.85546564 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 2.83960979 |
| 127 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81726144 |
| 128 | angiotensin maturation (GO:0002003) | 2.78047102 |
| 129 | regulation of humoral immune response (GO:0002920) | 2.77874272 |
| 130 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.77277994 |
| 131 | L-phenylalanine catabolic process (GO:0006559) | 2.77277994 |
| 132 | lipoprotein metabolic process (GO:0042157) | 2.75438704 |
| 133 | oligosaccharide biosynthetic process (GO:0009312) | 2.74993390 |
| 134 | blood coagulation, intrinsic pathway (GO:0007597) | 2.74585152 |
| 135 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.74467039 |
| 136 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.74467039 |
| 137 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.74467039 |
| 138 | regulation of cGMP metabolic process (GO:0030823) | 2.74324916 |
| 139 | regulation of systemic arterial blood pressure (GO:0003073) | 2.74067200 |
| 140 | hypotonic response (GO:0006971) | 2.73066456 |
| 141 | regulation of early endosome to late endosome transport (GO:2000641) | 2.72517289 |
| 142 | actin filament depolymerization (GO:0030042) | 2.71717720 |
| 143 | cholesterol homeostasis (GO:0042632) | 2.71553050 |
| 144 | transepithelial transport (GO:0070633) | 2.71446813 |
| 145 | cGMP-mediated signaling (GO:0019934) | 2.71014000 |
| 146 | sperm capacitation (GO:0048240) | 2.70944001 |
| 147 | galactose catabolic process (GO:0019388) | 2.70910322 |
| 148 | negative regulation of blood coagulation (GO:0030195) | 2.70538517 |
| 149 | negative regulation of hemostasis (GO:1900047) | 2.70538517 |
| 150 | fucosylation (GO:0036065) | 2.70504819 |
| 151 | L-fucose catabolic process (GO:0042355) | 2.70208746 |
| 152 | fucose catabolic process (GO:0019317) | 2.70208746 |
| 153 | L-fucose metabolic process (GO:0042354) | 2.70208746 |
| 154 | monocarboxylic acid transport (GO:0015718) | 2.69816579 |
| 155 | reverse cholesterol transport (GO:0043691) | 2.69462822 |
| 156 | phenylpropanoid metabolic process (GO:0009698) | 2.69461486 |
| 157 | sterol homeostasis (GO:0055092) | 2.69376028 |
| 158 | disruption of cells of other organism (GO:0044364) | 2.68926569 |
| 159 | killing of cells of other organism (GO:0031640) | 2.68926569 |
| 160 | transcytosis (GO:0045056) | 2.68673519 |
| 161 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67541818 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.66009507 |
| 163 | lipoprotein transport (GO:0042953) | 2.65706535 |
| 164 | neurotransmitter metabolic process (GO:0042133) | 2.64445784 |
| 165 | positive regulation of fatty acid oxidation (GO:0046321) | 2.64401495 |
| 166 | benzene-containing compound metabolic process (GO:0042537) | 2.63836423 |
| 167 | ethanol metabolic process (GO:0006067) | 2.63590141 |
| 168 | L-phenylalanine metabolic process (GO:0006558) | 2.61600581 |
| 169 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.61600581 |
| 170 | indolalkylamine metabolic process (GO:0006586) | 2.61230153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.31386195 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.51607974 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97910143 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.88600827 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69137248 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64216946 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.30943831 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.14946568 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.09139482 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.04659982 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.61089196 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.58470721 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52206843 |
| 14 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.48468214 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.39885242 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22310255 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18782233 |
| 18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.18594675 |
| 19 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.17578690 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.14179451 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98637434 |
| 22 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.88256230 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75918009 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.75437435 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71324819 |
| 26 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69367521 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68248802 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67205574 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66132118 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.54836913 |
| 31 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.54410470 |
| 32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.54406507 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45662204 |
| 34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43204141 |
| 35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43092385 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40627737 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40133245 |
| 38 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.39984902 |
| 39 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36656103 |
| 40 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36093063 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35500036 |
| 42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35093224 |
| 43 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32637882 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30618478 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29500388 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28106710 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27406806 |
| 48 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26232850 |
| 49 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.26039067 |
| 50 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25859845 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23597384 |
| 52 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22858469 |
| 53 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21966396 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21658086 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20242129 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18118436 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16581237 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16209510 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14542559 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12379368 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11486426 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09210915 |
| 63 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05547790 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05297723 |
| 65 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05021422 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04665326 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04480781 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03256419 |
| 69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03080735 |
| 70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02948845 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02497195 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02497195 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02416587 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01096229 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.99096305 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98783165 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98661748 |
| 78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98326492 |
| 79 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98312293 |
| 80 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97682416 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97176590 |
| 82 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.96366472 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96231721 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95695495 |
| 85 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95589513 |
| 86 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.95279506 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94604513 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94604513 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94443712 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94034856 |
| 91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93009889 |
| 92 | * CLOCK_20551151_ChIP-Seq_293T_Human | 0.92877179 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91938744 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91212390 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90967150 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90672715 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89026924 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88796076 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88361416 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88154524 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86505834 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.86369526 |
| 103 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86052142 |
| 104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85916069 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85539726 |
| 106 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85341970 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85316137 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85051053 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84989400 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84826990 |
| 111 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.84778992 |
| 112 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83715947 |
| 113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.83638267 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.83636706 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83557239 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82948688 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82725324 |
| 118 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81514031 |
| 119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80780557 |
| 120 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.80775316 |
| 121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79253947 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79164705 |
| 123 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.78929111 |
| 124 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78643032 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77721628 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76732012 |
| 127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75967549 |
| 128 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.75681361 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75626018 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75463571 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73389788 |
| 132 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72701678 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 0.72636002 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71803313 |
| 135 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71769071 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71047414 |
| 137 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70557652 |
| 138 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70453310 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70142350 |
| 140 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68924363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.18068937 |
| 2 | MP0002822_catalepsy | 6.09142926 |
| 3 | MP0003878_abnormal_ear_physiology | 4.79171866 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.79171866 |
| 5 | MP0005360_urolithiasis | 4.11327275 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.79812399 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 3.75461713 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.59297085 |
| 9 | MP0005257_abnormal_intraocular_pressure | 3.07355342 |
| 10 | MP0005167_abnormal_blood-brain_barrier | 2.92892807 |
| 11 | MP0003283_abnormal_digestive_organ | 2.90663212 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.81478033 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.77706987 |
| 14 | MP0001873_stomach_inflammation | 2.60547287 |
| 15 | MP0003195_calcinosis | 2.55920066 |
| 16 | MP0005365_abnormal_bile_salt | 2.47818127 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.38959821 |
| 18 | MP0003866_abnormal_defecation | 2.25520560 |
| 19 | MP0003252_abnormal_bile_duct | 2.13530008 |
| 20 | MP0001663_abnormal_digestive_system | 1.93342354 |
| 21 | MP0000462_abnormal_digestive_system | 1.88071947 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.84299830 |
| 23 | MP0010155_abnormal_intestine_physiology | 1.83603448 |
| 24 | MP0005381_digestive/alimentary_phenotyp | 1.80882413 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.78614737 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.76177602 |
| 27 | MP0002132_abnormal_respiratory_system | 1.72751538 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.72721515 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.72309167 |
| 30 | MP0003436_decreased_susceptibility_to | 1.70401021 |
| 31 | MP0005408_hypopigmentation | 1.68013494 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.63656699 |
| 33 | MP0000490_abnormal_crypts_of | 1.52150448 |
| 34 | MP0003868_abnormal_feces_composition | 1.46051033 |
| 35 | MP0004147_increased_porphyrin_level | 1.44298084 |
| 36 | MP0002796_impaired_skin_barrier | 1.43449826 |
| 37 | MP0005670_abnormal_white_adipose | 1.36873959 |
| 38 | MP0000566_synostosis | 1.36284313 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.33786250 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.33070060 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.32749104 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.28142509 |
| 43 | MP0005409_darkened_coat_color | 1.26122001 |
| 44 | MP0004185_abnormal_adipocyte_glucose | 1.24234481 |
| 45 | MP0001790_abnormal_immune_system | 1.22246038 |
| 46 | MP0005387_immune_system_phenotype | 1.22246038 |
| 47 | * MP0000477_abnormal_intestine_morphology | 1.21785345 |
| 48 | MP0001664_abnormal_digestion | 1.20626782 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.19677366 |
| 50 | MP0003724_increased_susceptibility_to | 1.19284798 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.19078923 |
| 52 | MP0004947_skin_inflammation | 1.15262404 |
| 53 | MP0001800_abnormal_humoral_immune | 1.14295061 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.13530121 |
| 55 | MP0004782_abnormal_surfactant_physiolog | 1.13083568 |
| 56 | MP0003941_abnormal_skin_development | 1.12732889 |
| 57 | MP0003122_maternal_imprinting | 1.11823602 |
| 58 | MP0002419_abnormal_innate_immunity | 1.11574883 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.08931621 |
| 60 | MP0001765_abnormal_ion_homeostasis | 1.08377841 |
| 61 | MP0000685_abnormal_immune_system | 1.06932744 |
| 62 | MP0005166_decreased_susceptibility_to | 1.04953342 |
| 63 | MP0005310_abnormal_salivary_gland | 1.02302008 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.01132526 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.00334648 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 0.99038981 |
| 67 | MP0000609_abnormal_liver_physiology | 0.97841918 |
| 68 | MP0003453_abnormal_keratinocyte_physiol | 0.97120663 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 0.96548159 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.96469530 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 0.96431019 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 0.93269474 |
| 73 | MP0003303_peritoneal_inflammation | 0.92372949 |
| 74 | MP0004043_abnormal_pH_regulation | 0.91945313 |
| 75 | MP0002166_altered_tumor_susceptibility | 0.89596346 |
| 76 | MP0009840_abnormal_foam_cell | 0.89268370 |
| 77 | MP0008872_abnormal_physiological_respon | 0.89050293 |
| 78 | MP0002060_abnormal_skin_morphology | 0.88824240 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.88724926 |
| 80 | MP0001835_abnormal_antigen_presentation | 0.86777448 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.86158409 |
| 82 | MP0005332_abnormal_amino_acid | 0.84114315 |
| 83 | MP0001216_abnormal_epidermal_layer | 0.83943910 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82657530 |
| 85 | MP0002452_abnormal_antigen_presenting | 0.82355388 |
| 86 | MP0005000_abnormal_immune_tolerance | 0.79800423 |
| 87 | MP0002933_joint_inflammation | 0.79655412 |
| 88 | MP0005164_abnormal_response_to | 0.79560470 |
| 89 | * MP0002723_abnormal_immune_serum | 0.78803629 |
| 90 | MP0002098_abnormal_vibrissa_morphology | 0.78755105 |
| 91 | MP0001849_ear_inflammation | 0.78674461 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.78188092 |
| 93 | MP0005451_abnormal_body_composition | 0.73534410 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.72138151 |
| 95 | MP0001764_abnormal_homeostasis | 0.71797749 |
| 96 | * MP0001819_abnormal_immune_cell | 0.71381937 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.71141557 |
| 98 | MP0005501_abnormal_skin_physiology | 0.70899656 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70762740 |
| 100 | MP0005083_abnormal_biliary_tract | 0.70294400 |
| 101 | * MP0002420_abnormal_adaptive_immunity | 0.69449917 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.68296261 |
| 103 | MP0000537_abnormal_urethra_morphology | 0.66767001 |
| 104 | MP0005448_abnormal_energy_balance | 0.66377753 |
| 105 | MP0003075_altered_response_to | 0.64459021 |
| 106 | MP0002148_abnormal_hypersensitivity_rea | 0.62552737 |
| 107 | MP0001756_abnormal_urination | 0.61926484 |
| 108 | MP0009115_abnormal_fat_cell | 0.61881017 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.61044068 |
| 110 | MP0003953_abnormal_hormone_level | 0.61036803 |
| 111 | MP0003879_abnormal_hair_cell | 0.59954361 |
| 112 | MP0000470_abnormal_stomach_morphology | 0.59183840 |
| 113 | MP0000604_amyloidosis | 0.58456198 |
| 114 | MP0003045_fibrosis | 0.57638763 |
| 115 | MP0000538_abnormal_urinary_bladder | 0.57177292 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.55579663 |
| 117 | MP0008469_abnormal_protein_level | 0.55156228 |
| 118 | MP0002006_tumorigenesis | 0.54597483 |
| 119 | * MP0008873_increased_physiological_sensi | 0.53834430 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.52266875 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.50763315 |
| 122 | MP0000383_abnormal_hair_follicle | 0.50662022 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.49487348 |
| 124 | * MP0005025_abnormal_response_to | 0.49183838 |
| 125 | * MP0009785_altered_susceptibility_to | 0.48472676 |
| 126 | MP0009053_abnormal_anal_canal | 0.46458488 |
| 127 | MP0005023_abnormal_wound_healing | 0.45910821 |
| 128 | MP0005671_abnormal_response_to | 0.44287343 |
| 129 | MP0004885_abnormal_endolymph | 0.44253405 |
| 130 | MP0006082_CNS_inflammation | 0.44181903 |
| 131 | MP0000377_abnormal_hair_follicle | 0.43284083 |
| 132 | MP0000467_abnormal_esophagus_morphology | 0.42878315 |
| 133 | MP0009764_decreased_sensitivity_to | 0.42042227 |
| 134 | MP0010771_integument_phenotype | 0.41924420 |
| 135 | MP0002971_abnormal_brown_adipose | 0.40999344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 5.70228946 |
| 2 | Pustule (HP:0200039) | 5.55474827 |
| 3 | Flat acetabular roof (HP:0003180) | 5.55040060 |
| 4 | Malnutrition (HP:0004395) | 5.53777731 |
| 5 | Decreased circulating renin level (HP:0003351) | 4.92389832 |
| 6 | Prostate neoplasm (HP:0100787) | 4.86845706 |
| 7 | Abnormality of small intestinal villus morphology (HP:0011472) | 4.75212321 |
| 8 | Villous atrophy (HP:0011473) | 4.75212321 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.49708390 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.23959371 |
| 11 | Oligomenorrhea (HP:0000876) | 4.06722481 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90528532 |
| 13 | Abnormality of the 1st metacarpal (HP:0010009) | 3.79454523 |
| 14 | Glomerulonephritis (HP:0000099) | 3.76194339 |
| 15 | Xanthomatosis (HP:0000991) | 3.75257735 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.63305553 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.57625192 |
| 18 | Ileus (HP:0002595) | 3.48023507 |
| 19 | Abdominal distention (HP:0003270) | 3.46210148 |
| 20 | Cupped ribs (HP:0000887) | 3.45513248 |
| 21 | Hyperaldosteronism (HP:0000859) | 3.45433804 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.39876512 |
| 23 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.36033709 |
| 24 | Abnormal tarsal ossification (HP:0008369) | 3.35164663 |
| 25 | Alopecia of scalp (HP:0002293) | 3.34982243 |
| 26 | Abnormality of complement system (HP:0005339) | 3.33269173 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32944289 |
| 28 | Joint hemorrhage (HP:0005261) | 3.17503122 |
| 29 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.14741866 |
| 30 | Abnormality of carpal bone ossification (HP:0006257) | 3.11727142 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.04509386 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.96723813 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95526022 |
| 34 | Hyponatremia (HP:0002902) | 2.92771821 |
| 35 | Deep venous thrombosis (HP:0002625) | 2.90573422 |
| 36 | Vascular calcification (HP:0004934) | 2.87786227 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.82741754 |
| 38 | Toxemia of pregnancy (HP:0100603) | 2.81740963 |
| 39 | Gingival bleeding (HP:0000225) | 2.79221473 |
| 40 | Hypoglycemic coma (HP:0001325) | 2.74706164 |
| 41 | Fat malabsorption (HP:0002630) | 2.70549437 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70054165 |
| 43 | Abnormality of the 2nd finger (HP:0004100) | 2.68564947 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63614511 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.62265027 |
| 46 | Ventricular tachycardia (HP:0004756) | 2.61866637 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61140896 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.60321893 |
| 49 | Acanthocytosis (HP:0001927) | 2.59905736 |
| 50 | Short phalanx of the thumb (HP:0009660) | 2.58522186 |
| 51 | Orchitis (HP:0100796) | 2.55153286 |
| 52 | Hypokalemia (HP:0002900) | 2.54913983 |
| 53 | Hypobetalipoproteinemia (HP:0003563) | 2.52800487 |
| 54 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.51265765 |
| 55 | Nephritis (HP:0000123) | 2.51061775 |
| 56 | Pili torti (HP:0003777) | 2.50060742 |
| 57 | Metabolic alkalosis (HP:0200114) | 2.48107408 |
| 58 | Abnormality of potassium homeostasis (HP:0011042) | 2.48093978 |
| 59 | Dehydration (HP:0001944) | 2.44002111 |
| 60 | Neonatal short-limb short stature (HP:0008921) | 2.41686662 |
| 61 | Hyperuricemia (HP:0002149) | 2.40324649 |
| 62 | Increased purine levels (HP:0004368) | 2.40324649 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40099774 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.39772011 |
| 65 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.38955579 |
| 66 | Palpitations (HP:0001962) | 2.38572665 |
| 67 | Abnormal foot bone ossification (HP:0010675) | 2.37916843 |
| 68 | Abnormal cartilage morphology (HP:0002763) | 2.37864216 |
| 69 | Abnormality of the nasal septum (HP:0000419) | 2.37334036 |
| 70 | Abnormal ossification of hand bones (HP:0005921) | 2.34533503 |
| 71 | Myositis (HP:0100614) | 2.34234074 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.33893593 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33893593 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.33656167 |
| 75 | Spontaneous abortion (HP:0005268) | 2.33199355 |
| 76 | Cheilitis (HP:0100825) | 2.32065425 |
| 77 | Abnormal hand bone ossification (HP:0010660) | 2.31943021 |
| 78 | Esophageal varix (HP:0002040) | 2.31741593 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 2.30066262 |
| 80 | Optic neuritis (HP:0100653) | 2.30066262 |
| 81 | Flattened epiphyses (HP:0003071) | 2.25349136 |
| 82 | Absent phalangeal crease (HP:0006109) | 2.22730476 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.21193457 |
| 84 | Abnormality of sodium homeostasis (HP:0010931) | 2.20933678 |
| 85 | Hoarse voice (HP:0001609) | 2.20429348 |
| 86 | Abnormality of chloride homeostasis (HP:0011422) | 2.20300998 |
| 87 | Joint swelling (HP:0001386) | 2.19521998 |
| 88 | Prolonged partial thromboplastin time (HP:0003645) | 2.19409643 |
| 89 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19042370 |
| 90 | Epidermoid cyst (HP:0200040) | 2.18328220 |
| 91 | Abnormality of macrophages (HP:0004311) | 2.18281143 |
| 92 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.17501206 |
| 93 | Hyperkalemia (HP:0002153) | 2.17068263 |
| 94 | Menorrhagia (HP:0000132) | 2.15817916 |
| 95 | Chronic diarrhea (HP:0002028) | 2.14430406 |
| 96 | Complement deficiency (HP:0004431) | 2.13775231 |
| 97 | Purpura (HP:0000979) | 2.11156204 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10945197 |
| 99 | Polygenic inheritance (HP:0010982) | 2.09667767 |
| 100 | Woolly hair (HP:0002224) | 2.08447250 |
| 101 | Fragile nails (HP:0001808) | 2.07586996 |
| 102 | Biliary tract neoplasm (HP:0100574) | 2.05858394 |
| 103 | Milia (HP:0001056) | 2.05574798 |
| 104 | Short hallux (HP:0010109) | 2.05044372 |
| 105 | Generalized aminoaciduria (HP:0002909) | 2.04914005 |
| 106 | Plantar hyperkeratosis (HP:0007556) | 2.04796651 |
| 107 | Facial shape deformation (HP:0011334) | 2.04578924 |
| 108 | Potter facies (HP:0002009) | 2.04578924 |
| 109 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.03331434 |
| 110 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02438677 |
| 111 | Onycholysis (HP:0001806) | 2.02128081 |
| 112 | Irregular epiphyses (HP:0010582) | 1.99765583 |
| 113 | Hyperammonemia (HP:0001987) | 1.99569017 |
| 114 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.98789225 |
| 115 | Widely patent fontanelles and sutures (HP:0004492) | 1.98631858 |
| 116 | Arthropathy (HP:0003040) | 1.95996331 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.95239565 |
| 118 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.94980443 |
| 119 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94814150 |
| 120 | Pulmonary embolism (HP:0002204) | 1.94422864 |
| 121 | Vertebral clefting (HP:0008428) | 1.92883392 |
| 122 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.92223560 |
| 123 | Flat capital femoral epiphysis (HP:0003370) | 1.91485100 |
| 124 | Short middle phalanx of finger (HP:0005819) | 1.88898565 |
| 125 | Micronodular cirrhosis (HP:0001413) | 1.87742764 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 1.87721982 |
| 127 | Hypotension (HP:0002615) | 1.86444896 |
| 128 | Pigmentary retinal degeneration (HP:0001146) | 1.86330858 |
| 129 | Focal segmental glomerulosclerosis (HP:0000097) | 1.85763837 |
| 130 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85361753 |
| 131 | Breech presentation (HP:0001623) | 1.85342661 |
| 132 | Alkalosis (HP:0001948) | 1.85259310 |
| 133 | Abnormal biliary tract morphology (HP:0012440) | 1.85207772 |
| 134 | Small epiphyses (HP:0010585) | 1.84841439 |
| 135 | Steatorrhea (HP:0002570) | 1.84165200 |
| 136 | Late onset (HP:0003584) | 1.83464698 |
| 137 | Hydroxyprolinuria (HP:0003080) | 1.83418197 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.83418197 |
| 139 | Hyperglycemia (HP:0003074) | 1.83155157 |
| 140 | Metaphyseal irregularity (HP:0003025) | 1.82348749 |
| 141 | Thrombophlebitis (HP:0004418) | 1.82127588 |
| 142 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81612512 |
| 143 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.81418811 |
| 144 | Vasculitis (HP:0002633) | 1.81351937 |
| 145 | Rickets (HP:0002748) | 1.80923928 |
| 146 | Petechiae (HP:0000967) | 1.80650885 |
| 147 | Proximal tubulopathy (HP:0000114) | 1.79938493 |
| 148 | Hemorrhage of the eye (HP:0011885) | 1.78169486 |
| 149 | Rectal prolapse (HP:0002035) | 1.76013638 |
| 150 | Epiphyseal dysplasia (HP:0002656) | 1.73429353 |
| 151 | Renal tubular acidosis (HP:0001947) | 1.70309862 |
| 152 | Hypochromic anemia (HP:0001931) | 1.69448361 |
| 153 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.69356398 |
| 154 | Abnormality of vitamin B metabolism (HP:0004340) | 1.67025504 |
| 155 | Pancreatitis (HP:0001733) | 1.66643797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K2 | 4.55127316 |
| 2 | MET | 4.31482257 |
| 3 | KSR2 | 4.04869603 |
| 4 | MAP2K2 | 3.79966592 |
| 5 | FRK | 3.03790452 |
| 6 | FGFR3 | 2.68936177 |
| 7 | NME1 | 2.28408109 |
| 8 | MST1R | 11.7292580 |
| 9 | MAP2K1 | 1.92563381 |
| 10 | TAOK3 | 1.86494351 |
| 11 | RIPK1 | 1.83584221 |
| 12 | LMTK2 | 1.50585637 |
| 13 | MAP3K1 | 1.49697636 |
| 14 | CDK12 | 1.34237997 |
| 15 | ERN1 | 1.30427666 |
| 16 | MAP4K1 | 1.28929284 |
| 17 | PRKG2 | 1.25548111 |
| 18 | OXSR1 | 1.25155378 |
| 19 | MYLK | 1.24745469 |
| 20 | MST4 | 1.23826837 |
| 21 | EPHA2 | 1.23337348 |
| 22 | EPHB2 | 1.21920807 |
| 23 | TXK | 1.18568985 |
| 24 | MAP3K12 | 1.12120346 |
| 25 | TESK1 | 1.12038526 |
| 26 | BLK | 1.07841208 |
| 27 | CDK9 | 1.06294409 |
| 28 | ZAP70 | 1.03895359 |
| 29 | STK24 | 1.03318801 |
| 30 | MAP3K8 | 1.01378923 |
| 31 | IRAK1 | 0.98828645 |
| 32 | IRAK4 | 0.94345790 |
| 33 | GRK6 | 0.88739202 |
| 34 | EEF2K | 0.87666648 |
| 35 | RIPK4 | 0.87662691 |
| 36 | FGR | 0.86763460 |
| 37 | MAP3K14 | 0.84195406 |
| 38 | RET | 0.80269228 |
| 39 | EPHB1 | 0.80200097 |
| 40 | TGFBR2 | 0.78601645 |
| 41 | PRKCQ | 0.75205248 |
| 42 | MATK | 0.73854478 |
| 43 | YES1 | 0.72698043 |
| 44 | PTK6 | 0.72087624 |
| 45 | TAOK1 | 0.70998066 |
| 46 | PTK2 | 0.70712959 |
| 47 | SYK | 0.69520626 |
| 48 | FGFR1 | 0.65040723 |
| 49 | CSK | 0.64031063 |
| 50 | TYRO3 | 0.58228102 |
| 51 | KDR | 0.57315615 |
| 52 | RPS6KB2 | 0.56919324 |
| 53 | DDR2 | 0.56562860 |
| 54 | DMPK | 0.55560404 |
| 55 | LCK | 0.54922222 |
| 56 | ADRBK2 | 0.54915293 |
| 57 | BCKDK | 0.53230593 |
| 58 | JAK2 | 0.52886422 |
| 59 | WNK1 | 0.52389111 |
| 60 | BCR | 0.51925514 |
| 61 | FGFR4 | 0.51569774 |
| 62 | MAP3K6 | 0.51475210 |
| 63 | MAPKAPK2 | 0.51403277 |
| 64 | PIK3CG | 0.49910524 |
| 65 | JAK1 | 0.48639305 |
| 66 | CSF1R | 0.47635279 |
| 67 | DYRK1B | 0.45037566 |
| 68 | SGK1 | 0.44567918 |
| 69 | STK10 | 0.44271414 |
| 70 | * LYN | 0.42659525 |
| 71 | PDK2 | 0.42370184 |
| 72 | IKBKB | 0.41808021 |
| 73 | MAP3K11 | 0.40254533 |
| 74 | LIMK1 | 0.39658285 |
| 75 | FER | 0.39380115 |
| 76 | TBK1 | 0.38102870 |
| 77 | NUAK1 | 0.37503993 |
| 78 | SIK1 | 0.36950803 |
| 79 | JAK3 | 0.36742236 |
| 80 | ACVR1B | 0.34802716 |
| 81 | CDK3 | 0.34655334 |
| 82 | ERBB2 | 0.34264808 |
| 83 | EPHA3 | 0.33653959 |
| 84 | TRPM7 | 0.33323229 |
| 85 | PRKAA1 | 0.32498567 |
| 86 | PKN2 | 0.31759537 |
| 87 | SIK2 | 0.31325562 |
| 88 | TESK2 | 0.31223357 |
| 89 | MAPK11 | 0.31197865 |
| 90 | SGK494 | 0.30998693 |
| 91 | SGK223 | 0.30998693 |
| 92 | PAK4 | 0.30541584 |
| 93 | BMX | 0.30324344 |
| 94 | AKT3 | 0.30213509 |
| 95 | NLK | 0.30112912 |
| 96 | PRKCD | 0.29986176 |
| 97 | PDGFRB | 0.29833477 |
| 98 | CAMK2G | 0.29788503 |
| 99 | MAP3K3 | 0.28489458 |
| 100 | PRKCA | 0.27486127 |
| 101 | ERBB4 | 0.27259804 |
| 102 | BMPR1B | 0.26095662 |
| 103 | CAMK2B | 0.26031931 |
| 104 | PDPK1 | 0.25797060 |
| 105 | TGFBR1 | 0.24134108 |
| 106 | DAPK3 | 0.23713863 |
| 107 | IGF1R | 0.23148269 |
| 108 | FYN | 0.22672385 |
| 109 | PRKAA2 | 0.22624912 |
| 110 | WNK4 | 0.22097410 |
| 111 | MAPKAPK5 | 0.20152265 |
| 112 | ITK | 0.20104342 |
| 113 | PRKCI | 0.19269488 |
| 114 | MAP2K6 | 0.18584862 |
| 115 | TTN | 0.18236377 |
| 116 | IKBKE | 0.17366515 |
| 117 | * CAMK2D | 0.17362118 |
| 118 | MELK | 0.17162582 |
| 119 | PDK1 | 0.16411340 |
| 120 | * SRC | 0.15989618 |
| 121 | PTK2B | 0.14383875 |
| 122 | ROCK1 | 0.14208035 |
| 123 | GRK1 | 0.13555927 |
| 124 | PRKACG | 0.12935402 |
| 125 | STK39 | 0.12544150 |
| 126 | AURKB | 0.11856959 |
| 127 | MAPKAPK3 | 0.11337277 |
| 128 | MAPK4 | 0.10800675 |
| 129 | FGFR2 | 0.10711326 |
| 130 | RPS6KA1 | 0.10247010 |
| 131 | MAP3K10 | 0.09005690 |
| 132 | MAP3K7 | 0.08959917 |
| 133 | TTK | 0.08699083 |
| 134 | PRKCZ | 0.08354108 |
| 135 | TYK2 | 0.08317411 |
| 136 | MAP2K3 | 0.07891783 |
| 137 | CDC42BPA | 0.07202870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 6.54225201 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 3.61193923 |
| 3 | Bile secretion_Homo sapiens_hsa04976 | 2.97149912 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.88537859 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.48363829 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.47314692 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43755171 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.33476265 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14591996 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03386159 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01642869 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01036762 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86582498 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.80744638 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.75751739 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69920088 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68910341 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65348886 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.55127019 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.47503217 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45700588 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44124557 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43921738 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42786838 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41312393 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37962703 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31587890 |
| 28 | Thyroid cancer_Homo sapiens_hsa05216 | 1.29584226 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.23311447 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22189085 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.21808265 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18583853 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15435978 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14162147 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13802539 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11579440 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10150473 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09379364 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08239790 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.07733746 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06595892 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.05334984 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05333480 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04737372 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02809060 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 1.00407264 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91460830 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90250231 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88976099 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87573047 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87341061 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87053851 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86469091 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84346037 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82560599 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.81623787 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81272214 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77437943 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77214972 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75407027 |
| 61 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73647539 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72590944 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.72136170 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69315902 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.68752910 |
| 66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66740380 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66682760 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65311621 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64199922 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63619049 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.63079038 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62789190 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.62571321 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60413403 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59766253 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58459607 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.56783745 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56360697 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55611514 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54849930 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.54236900 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54191891 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52914418 |
| 84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52130246 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51907945 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.51834547 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51402666 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49886730 |
| 89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49337915 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48065690 |
| 91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47375695 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46691830 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46439083 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46175193 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.45884171 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44910908 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44741266 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44181017 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42065079 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40414258 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40335564 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39730756 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.38658223 |
| 104 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38419217 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35882057 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35204782 |
| 107 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33284024 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32639477 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31910926 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29542596 |
| 111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29010620 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.27196904 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27192258 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26314571 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25479616 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24511184 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24479369 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.23679501 |
| 119 | Tuberculosis_Homo sapiens_hsa05152 | 0.22540410 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.22068833 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21962377 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.21542535 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21446093 |
| 124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.21055521 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20868841 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.16559895 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.14405291 |

